We reduced our fair value estimate to $15.50 per share from $27.20 to account for greater headwinds as a newly stand-alone company since its spinoff from Labcorp in 2023, which will weigh on revenue ...

A decade of studies from labs around the world provide a growing evidence base that increasing the power of the brain's gamma rhythms could help fight Alzheimer's, and perhaps other, neurological ...

CStone Pharmaceuticals ('CStone', HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that the first patient ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...

A decade after scientists at The Picower Institute for Learning and Memory at MIT first began testing whether sensory ...

The National Institutes of Health (NIH) serves as an important source of funding for clinical trials in children, especially ...

Patrick Tan’s project in Singapore will create Asia’s first functional precision medicine system with the potential to fine-tune treatments and drug responses for Asians.

A new computational tool allows researchers to understand how the diverse cell types of the human body are made during ...

A decade after scientists in The Picower Institute for Learning and Memory at MIT first began testing whether sensory stimulation of the brain's 40Hz "gamma" frequency rhythms could treat Alzheimer's ...

A new generation of therapeutics looks beyond simply reengineering the gut microbiome to exploiting multiple pathways for novel microbiome and microbial applications.

Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...